Cromos Pharma, where the patients are

Study Conduct

Drug company success depends on new development paradigms

Wednesday, January 8, 2014 01:23 PM

While many drug developers continue to improve clinical trial operational efficiency to increase the pace of new product introductions, their medium- and long-term success increasingly will depend on their ability to embrace more efficient R&D models, according to the Tufts Center for the Study of Drug Development.

More... »

CRF Health eCOA webinar series

TauRx expands Alzheimer's clinical trials in the U.S.

Monday, January 6, 2014 11:55 AM

TauRx Therapeutics, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer's disease, has expanded its international clinical trials by adding new research centers across the U.S. The addition of 35 clinical research centers means more patients suffering from mild or moderate Alzheimer's, and their caregivers, will have an opportunity to see if they qualify for participation in TauRx's Alzheimer's clinical trials.

More... »

ideaPoint launches multi-sponsor portal

Thursday, January 2, 2014 10:35 AM

ideaPoint, a provider of partnering and collaboration systems for global enterprises, has announced the availability of a new portal providing a secure system for researchers to request access to anonymized, patient-level clinical trial data provided by sponsors ( Study sponsors who have committed to provide data through the site currently include Boehringer Ingelheim, GlaxoSmithKline, Roche, Sanofi and ViiV Healthcare.

More... »

BIA says E.U. Clinical Trial Regulation misses goal to make E.U. more attractive for trial conduct

Thursday, January 2, 2014 10:28 AM

The endorsement by the E.U. Committee of Permanent Representatives of the political agreement reached by the Lithuanian E.U. Council Presidency and the European Parliament, on the compromise text of the proposed E.U. Clinical Trials Regulation looks set to not deliver on the initial goal set by the European Commission (E.C.) when it launched the process in July 2012 of making the E.U. a more attractive location to conduct clinical trials.

More... »

EFPIA, PhRMA trial data sharing plan goes into effect

Thursday, January 2, 2014 10:22 AM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) have implemented the joint Principles for Responsible Clinical Trial Data Sharing.

More... »

Kurt+Peter Foundation builds online patient registry for muscular dystrophy

Wednesday, December 18, 2013 01:49 PM

The Kurt+Peter Foundation, a nonprofit group that supports research into potential therapies, has released the first patient registry for Limb Girdle Muscular Dystrophy, type 2C, also known as gamma sarcoglycanopathy (LGMD2C). 

More... »

NIH launches regional Stroke Trials Network

Wednesday, December 18, 2013 01:39 PM

The National Institutes of Health has launched a network of 25 regional stroke centers working with nearby satellite facilities spanning the country. They will include teams of researchers representing every medical specialty needed for stroke care and will address the three prongs of stroke research: prevention, treatment and recovery.

More... »

Report: GBSI addresses irreproducibility of research findings

Monday, December 16, 2013 02:23 PM

The Global Biological Standards Institute (GBSI) has presented findings from the first comprehensive report on the state of life science research quality. GBSI commissioned the report to assess the quality of R&D methodologies, identify areas of concern and establish recommendations for meaningful change.

More... »

Innovative Medicines Initiative launches novel trial design in Alzheimer’s trial

Friday, December 13, 2013 02:01 PM

The Innovative Medicines Initiative (IMI) is launching a major new project that will pioneer a novel, more flexible approach to clinical trials of drugs designed to prevent Alzheimer’s disease. The $72.7 million project, which will see several biotechnology and pharmaceutical companies working closely together, will aim to speed up drug development and patient access to the latest treatments.

More... »

2013 human research protection awards announced

Friday, December 13, 2013 01:48 PM

Awards for excellence in human research protection for 2013 have been announced by Dr. Peter G. Goldschmidt, president and founder of the Health Improvement Institute.

More... »

CenterWatch Clinical Trial Survey



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs